About Brix Biopharma Private Limited
Data last updated:
Brix Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2019PTC332985. Its GSTIN is 27AAICB7477P1ZR (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Atish Ghisulal Jain (Managing Director) and Najul Vinod Nagda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.59 Cr, a growth of 76% compared to the previous year. For the same year it recorded a net profit of ₹59.49 Lakh (net margin 2.6%) and EBITDA of ₹2.22 Cr (EBITDA margin 9.8%). Revenue has grown at a compounded annual rate (CAGR) of 95% over three years.
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹7.6 Cr on record.
For more details, the company can be reached via its website brixbiopharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address903 9th Floor Sunshine Tower S. B. Road, Dadar West, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Brix Biopharma Private Limited
The main business activity of Brix Biopharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Brix Biopharma Private Limited FY 2025 filings available
Brix Biopharma Private Limited reported revenue of ₹22.59 Cr (up 76% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Brix Biopharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 95% over three years, including 76% growth in the latest year. EBITDA rose 582% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Brix Biopharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.22 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹59.49 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Brix Biopharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Brix Biopharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Brix Biopharma Private Limited
Brix Biopharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Biopharma, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wallace Laboratories Private Limited | ₹22.71 Cr (FY 2023) | •••• | •••• | 27.0% | •••• | Goa, India |
| Dr. Smiths Biotech Private Limited | ₹22.7 Cr (FY 2023) | •••• | •••• | 40.0% | •••• | Pune, Maharashtra, India |
| RKS Cardio Devices Private Limited | ₹22.67 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Lucknow, Uttar Pradesh, India |
| Astamed Healthcare ( India ) Private Limited | ₹22.66 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Mumbai, Maharashtra, India |
| Disto Pharmaceuticals Private Limited | ₹22.63 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Hyderabad, Telangana, India |
| Brix Biopharma Private Limited this company | ₹22.59 Cr (FY 2024) | •••• | •••• | 76.0% | •••• | Mumbai, Maharashtra, India |
| Mapaex Remedies Private Limited | ₹22.57 Cr (FY 2017) | •••• | •••• | -52.0% | •••• | Wadhwan, Gujarat, India |
| Athulitha Laboratories Private Limited | ₹22.56 Cr (FY 2024) | •••• | •••• | 66.0% | •••• | Hyderabad, Telangana, India |
| Beryl Drugs Limited Listed | ₹22.55 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Indore, Madhya Pradesh, India |
| Sherrington Pharmaceuticals Private Limited | ₹22.55 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Hyderabad, Telangana, India |
| Relief Biotech Private Limited | ₹22.54 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Roorkee, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Brix Biopharma by revenue in the Pharma industry (Biopharma, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Brix Biopharma Private Limited
Brix Biopharma Private Limited is audited by RAKESH V PANCHMATIA & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAKESH V PANCHMATIA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Brix Biopharma Private Limited
Brix Biopharma has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Najul Vinod Nagda | Director | 15 Nov 2019 | 6 Years 10 Months | Current |
| Priyank Nitin Jain Punmiya Also directs: 02 Pharmacy Global LLP | Director | 15 Nov 2019 | 6 Years 10 Months | Current |
| Dipesh Shashikant Shah | Director | 14 Feb 2024 | 2 Years 7 Months | Current |
| Kamlesh Ghisulal Jain Also directs: Dheer Health Care Private Limited | Director | 14 Feb 2024 | 2 Years 7 Months | Current |
| Atish Ghisulal Jain Also directs: Dheer Health Care Private Limited | Managing Director | 14 Feb 2024 | 2 Years 7 Months | Current |
Ownership and Shareholding of Brix Biopharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Brix Biopharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2024 | Others | ₹7.6 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Brix Biopharma Private Limited
Employment history and EPFO contributions of people linked to Brix Biopharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Brix Biopharma Private Limited
Brix Biopharma Private Limited has 5 board changes on record since 2019: 5 appointments. The latest: Atish Ghisulal Jain was appointed as Managing Director on 14 Feb 2024.
Credit Ratings, Litigation & Regulatory Alerts for Brix Biopharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Brix Biopharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Brix Biopharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Brix Biopharma Private Limited
Brix Biopharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICB7477P1ZR | Maharashtra | Active | 25 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Brix Biopharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brix Biopharma Private Limited
Brix Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 November 2019 (7+ years old) and is registered under CIN U24230MH2019PTC332985.
Brix Biopharma reported revenue of ₹22.59 Cr for FY 2024 (up 76% YoY).
Brix Biopharma has 5 current directors:
- Atish Ghisulal Jain - Managing Director
- Najul Vinod Nagda - Director
- Priyank Nitin Jain Punmiya - Director
- Dipesh Shashikant Shah - Director
- Kamlesh Ghisulal Jain - Director
Brix Biopharma reported a net profit of ₹59.49 Lakh (net margin 2.6%) and EBITDA of ₹2.22 Cr (EBITDA margin 9.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Brix Biopharma is 95% over three years. In the latest year (FY 2024) revenue rose 76%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Brix Biopharma is 27AAICB7477P1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Brix Biopharma is U24230MH2019PTC332985. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brix Biopharma was incorporated on 15 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Brix Biopharma by revenue are Wallace Laboratories Private Limited, Dr. Smiths Biotech Private Limited, RKS Cardio Devices Private Limited, Astamed Healthcare ( India ) Private Limited, Disto Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Biopharma, Formulations).
Atish Ghisulal Jain was appointed as Managing Director on 14 Feb 2024. Dipesh Shashikant Shah was appointed as Director on 14 Feb 2024. Kamlesh Ghisulal Jain was appointed as Director on 14 Feb 2024. Brix Biopharma has 5 board changes on record in total.
Brix Biopharma can be reached through the website brixbiopharma.in. Its registered office is in Mumbai, Maharashtra, India.